Get startedLog in
    Picture of Radiopharm Theranostics logo

    RAD — Radiopharm Theranostics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Radiopharm Gets DSMC Nod To Accelerate Phase 1 Dose Escalation Trial Of 177Lu-RAD202

    Picture of Radiopharm Theranostics logoRadiopharm Theranostics
    01/10/2025 14:43
    Oct 1 (Reuters) - Radiopharm Theranostics Ltd RAD.AX:

RADIOPHARM THERANOSTICS RECEIVES POSITIVE RECOMMENDATION FROM DATA SAFETY AND MONITORING COMMITTEE (DSMC) TO ACCELERATE 177LU-RAD202 PHASE 1 ‘HEAT’ DOSE ESCALATION CLINICAL TRIAL

Source text: ID:nGNX5hr6nY

Further company coverage: RAD.AX

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Radiopharm Theranostics

    See all news